Clinical Trial Update: Long-term Efficacy and Safety Study of GV-971 [Phase 4]

View source ↗

Summary

This document reports a Phase 4 long-term efficacy and safety study of GV-971 for Alzheimer's disease, with the trial currently active but not recruiting. It in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GV-971 (Sodium oligomannate)

Snippet

Sponsor: Green Valley (Shanghai) Pharmaceuticals Co., Ltd. | Conditions: Alzheimer Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING